JPS6272A - Benzo(a)phenazine derivative - Google Patents
Benzo(a)phenazine derivativeInfo
- Publication number
- JPS6272A JPS6272A JP61064410A JP6441086A JPS6272A JP S6272 A JPS6272 A JP S6272A JP 61064410 A JP61064410 A JP 61064410A JP 6441086 A JP6441086 A JP 6441086A JP S6272 A JPS6272 A JP S6272A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- group
- reference example
- formula
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SEXRCKWGFSXUOO-UHFFFAOYSA-N benzo[a]phenazine Chemical class C1=CC=C2N=C3C4=CC=CC=C4C=CC3=NC2=C1 SEXRCKWGFSXUOO-UHFFFAOYSA-N 0.000 title claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 41
- 238000002360 preparation method Methods 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 abstract description 2
- 206010059866 Drug resistance Diseases 0.000 abstract description 2
- 150000003973 alkyl amines Chemical class 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- IVCYJYFCSFUVOU-UHFFFAOYSA-N ethyl 1-hydroxy-3,4-dioxonaphthalene-2-carboxylate Chemical compound C1=CC=C2C(=O)C(=O)C(C(=O)OCC)=C(O)C2=C1 IVCYJYFCSFUVOU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- -1 methoxy, ethoxy, propoxy Chemical group 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- 125000005605 benzo group Chemical group 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- KPZYYKDXZKFBQU-UHFFFAOYSA-N phenazine-1-carboxamide Chemical compound C1=CC=C2N=C3C(C(=O)N)=CC=CC3=NC2=C1 KPZYYKDXZKFBQU-UHFFFAOYSA-N 0.000 description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- JGCSKOVQDXEQHI-UHFFFAOYSA-N phenazine-1-carboxylic acid Chemical compound C1=CC=C2N=C3C(C(=O)O)=CC=CC3=NC2=C1 JGCSKOVQDXEQHI-UHFFFAOYSA-N 0.000 description 4
- 150000004986 phenylenediamines Chemical class 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VZFDKPOVLPUJET-UHFFFAOYSA-N methyl 5-amino-2-ethoxy-4-nitrobenzoate Chemical compound CCOC1=CC([N+]([O-])=O)=C(N)C=C1C(=O)OC VZFDKPOVLPUJET-UHFFFAOYSA-N 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000978776 Senegalia senegal Species 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 150000001263 acyl chlorides Chemical class 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- SUSCULWPEGQASI-UHFFFAOYSA-N methyl 4,5-diamino-2-methoxybenzoate Chemical compound COC(=O)C1=CC(N)=C(N)C=C1OC SUSCULWPEGQASI-UHFFFAOYSA-N 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- LJNYGEHLBVCTOO-UHFFFAOYSA-N 2,2-dimethylpropyl 5-amino-2-methoxy-4-nitrobenzoate Chemical compound COC1=CC([N+]([O-])=O)=C(N)C=C1C(=O)OCC(C)(C)C LJNYGEHLBVCTOO-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- FOXLFUZFWTYAME-UHFFFAOYSA-N 3-acetamido-2-nitrobenzoic acid Chemical compound CC(=O)NC1=CC=CC(C(O)=O)=C1[N+]([O-])=O FOXLFUZFWTYAME-UHFFFAOYSA-N 0.000 description 1
- AFPHTEQTJZKQAQ-UHFFFAOYSA-N 3-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1 AFPHTEQTJZKQAQ-UHFFFAOYSA-N 0.000 description 1
- QYPYVSKQIJXYMA-UHFFFAOYSA-N 4,5-diamino-2-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC(N)=C(N)C=C1C(=O)N(C)C QYPYVSKQIJXYMA-UHFFFAOYSA-N 0.000 description 1
- OTLNPYWUJOZPPA-UHFFFAOYSA-M 4-nitrobenzoate Chemical compound [O-]C(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-M 0.000 description 1
- MCMWBISEZKTTRZ-UHFFFAOYSA-N 5-amino-2-methoxy-4-nitrobenzoic acid Chemical compound COC1=CC([N+]([O-])=O)=C(N)C=C1C(O)=O MCMWBISEZKTTRZ-UHFFFAOYSA-N 0.000 description 1
- CTRUXKTYESKXTL-UHFFFAOYSA-N 5-amino-2-methoxy-n,n-dimethyl-4-nitrobenzamide Chemical compound COC1=CC([N+]([O-])=O)=C(N)C=C1C(=O)N(C)C CTRUXKTYESKXTL-UHFFFAOYSA-N 0.000 description 1
- YTZKRSYFDRSKQR-UHFFFAOYSA-N 5-amino-n-ethyl-2-methoxy-4-nitrobenzamide Chemical compound CCNC(=O)C1=CC(N)=C([N+]([O-])=O)C=C1OC YTZKRSYFDRSKQR-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000011765 DBA/2 mouse Methods 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- GEFDRROBUCULOD-UHFFFAOYSA-N N-acetyl-5-aminosalicylic acid Chemical compound CC(=O)NC1=CC=C(O)C(C(O)=O)=C1 GEFDRROBUCULOD-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 101100289792 Squirrel monkey polyomavirus large T gene Proteins 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- HYAPWOCEMUCRRG-UHFFFAOYSA-N butyl 5-acetamido-2-butoxy-4-nitrobenzoate Chemical compound CCCCOC(=O)C1=CC(NC(C)=O)=C([N+]([O-])=O)C=C1OCCCC HYAPWOCEMUCRRG-UHFFFAOYSA-N 0.000 description 1
- SAXWAJCDLGYRJS-UHFFFAOYSA-N butyl 5-acetamido-2-butoxybenzoate Chemical compound CCCCOC(=O)C1=CC(NC(C)=O)=CC=C1OCCCC SAXWAJCDLGYRJS-UHFFFAOYSA-N 0.000 description 1
- MJXXNLATJGCXAJ-UHFFFAOYSA-N butyl 5-amino-2-butoxy-4-nitrobenzoate Chemical compound CCCCOC(=O)C1=CC(N)=C([N+]([O-])=O)C=C1OCCCC MJXXNLATJGCXAJ-UHFFFAOYSA-N 0.000 description 1
- NXVLXUVPKFQWNP-UHFFFAOYSA-N butyl 5-amino-2-ethoxy-4-nitrobenzoate Chemical compound CCCCOC(=O)C1=CC(N)=C([N+]([O-])=O)C=C1OCC NXVLXUVPKFQWNP-UHFFFAOYSA-N 0.000 description 1
- RTCPCUYINUFVSH-UHFFFAOYSA-N butyl 5-amino-4-nitro-2-propoxybenzoate Chemical compound CCCCOC(=O)C1=CC(N)=C([N+]([O-])=O)C=C1OCCC RTCPCUYINUFVSH-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WLXALCKAKGDNAT-UHFFFAOYSA-N diazoethane Chemical compound CC=[N+]=[N-] WLXALCKAKGDNAT-UHFFFAOYSA-N 0.000 description 1
- KPUNOVLMCQQCSK-UHFFFAOYSA-N diazomethane;ethoxyethane Chemical compound C=[N+]=[N-].CCOCC KPUNOVLMCQQCSK-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- HPCYANYWTUCLMH-UHFFFAOYSA-N ethyl 4-amino-3-nitrobenzoate Chemical group CCOC(=O)C1=CC=C(N)C([N+]([O-])=O)=C1 HPCYANYWTUCLMH-UHFFFAOYSA-N 0.000 description 1
- GNOPXDFXMYMEBF-UHFFFAOYSA-N ethyl 5-acetamido-2-ethoxy-4-nitrobenzoate Chemical compound CCOC(=O)C1=CC(NC(C)=O)=C([N+]([O-])=O)C=C1OCC GNOPXDFXMYMEBF-UHFFFAOYSA-N 0.000 description 1
- URAJMVZKUKFRBW-UHFFFAOYSA-N ethyl 5-amino-4-nitro-2-propoxybenzoate Chemical compound NC=1C(=CC(=C(C(=O)OCC)C1)OCCC)[N+](=O)[O-] URAJMVZKUKFRBW-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-N iron;hydrochloride Chemical compound Cl.[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- RCTUOQROYPVANI-UHFFFAOYSA-N methyl 4,5-diamino-2-ethoxybenzoate Chemical compound CCOC1=CC(N)=C(N)C=C1C(=O)OC RCTUOQROYPVANI-UHFFFAOYSA-N 0.000 description 1
- JNEVVSKBIZXKQR-UHFFFAOYSA-N methyl 4-acetamido-2-chloro-5-nitrobenzoate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=C(NC(C)=O)C=C1Cl JNEVVSKBIZXKQR-UHFFFAOYSA-N 0.000 description 1
- JEJJIGFNMPUSSF-UHFFFAOYSA-N methyl 4-acetamido-2-hydroxy-5-nitrobenzoate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=C(NC(C)=O)C=C1O JEJJIGFNMPUSSF-UHFFFAOYSA-N 0.000 description 1
- JALSFXCPHVLKBQ-UHFFFAOYSA-N methyl 4-amino-2-hydroxy-5-nitrobenzoate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=C(N)C=C1O JALSFXCPHVLKBQ-UHFFFAOYSA-N 0.000 description 1
- NXPCLYXQMIICCF-UHFFFAOYSA-N methyl 5-amino-2-butoxy-4-nitrobenzoate Chemical compound CCCCOC1=CC([N+]([O-])=O)=C(N)C=C1C(=O)OC NXPCLYXQMIICCF-UHFFFAOYSA-N 0.000 description 1
- GCQTXPYGJTZUTQ-UHFFFAOYSA-N methyl 5-amino-2-methoxy-4-nitrobenzoate Chemical compound COC(=O)C1=CC(N)=C([N+]([O-])=O)C=C1OC GCQTXPYGJTZUTQ-UHFFFAOYSA-N 0.000 description 1
- IDZWKWPHPHPACG-UHFFFAOYSA-N methyl 5-amino-4-nitro-2-propoxybenzoate Chemical compound CCCOC1=CC([N+]([O-])=O)=C(N)C=C1C(=O)OC IDZWKWPHPHPACG-UHFFFAOYSA-N 0.000 description 1
- DGSXFRJEHFETBL-UHFFFAOYSA-N methyl 6-[2-(dimethylamino)ethylcarbamoyl]-5-hydroxy-10-methoxybenzo[a]phenazine-9-carboxylate Chemical compound COC(=O)c1cc2nc3c(C(=O)NCCN(C)C)c(O)c4ccccc4c3nc2cc1OC DGSXFRJEHFETBL-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- SCZVXVGZMZRGRU-UHFFFAOYSA-N n'-ethylethane-1,2-diamine Chemical compound CCNCCN SCZVXVGZMZRGRU-UHFFFAOYSA-N 0.000 description 1
- QAXZWHGWYSJAEI-UHFFFAOYSA-N n,n-dimethylformamide;ethanol Chemical compound CCO.CN(C)C=O QAXZWHGWYSJAEI-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000000802 nitrating effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- GGHDAUPFEBTORZ-UHFFFAOYSA-N propane-1,1-diamine Chemical compound CCC(N)N GGHDAUPFEBTORZ-UHFFFAOYSA-N 0.000 description 1
- JUCCGZREJPXVNZ-UHFFFAOYSA-N propyl 5-acetamido-2-propoxybenzoate Chemical compound CCCOC(=O)C1=CC(NC(C)=O)=CC=C1OCCC JUCCGZREJPXVNZ-UHFFFAOYSA-N 0.000 description 1
- OEBQUJPCZDZLTC-UHFFFAOYSA-N propyl 5-acetamido-4-nitro-2-propoxybenzoate Chemical compound CCCOC(=O)C1=CC(NC(C)=O)=C([N+]([O-])=O)C=C1OCCC OEBQUJPCZDZLTC-UHFFFAOYSA-N 0.000 description 1
- QAZVZYVTFYYKJL-UHFFFAOYSA-N propyl 5-amino-4-nitro-2-propoxybenzoate Chemical compound CCCOC(=O)C1=CC(N)=C([N+]([O-])=O)C=C1OCCC QAZVZYVTFYYKJL-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fireproofing Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の
本発明は、抗腫瘍活性を有する新規ベンゾ[α]フェナ
ジンー6−カルポキサミド誘導体に関し、癌の治療に有
用な化合物を提供するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel benzo[α]phenazine-6-carpoxamide derivatives having antitumor activity, and provides compounds useful in the treatment of cancer.
良未ム韮遣
従来、ベンゾ[(Z]フェナジン誘導体で抗腫瘍作用が
知られているものは、5cience Reports
ofthe Re5earch In5titute
of Iohoku University−C16
巻 1−2号 18〜26頁1969年に記載きれてい
る化合物があるにすぎない。Conventionally, benzo[(Z]phenazine derivatives known to have antitumor effects are 5science Reports)
of the Re5search In5tituto
of Iohoku University-C16
There is only one compound that was completely described in Vol. 1-2, pp. 18-26, 1969.
明が 決しようとする間 。While Ming was trying to decide.
しかしながら、上記およびその他の既存の制癌剤は、有
効性および安全性の点で未だ十分とは言い難い。However, the above-mentioned and other existing anticancer drugs are still far from satisfactory in terms of efficacy and safety.
ra題、1.を するための手段
本発明者らはベンゾ[a]フェナジン誘導体の有効性向
上を目的に鋭意検討した結果、優れた抗腫瘍活性を示す
ベンゾ[aコフェナジンー6−カルボキサミド誘導体を
見い出し本発明を完成した。Ra title, 1. As a result of intensive studies aimed at improving the effectiveness of benzo[a]phenazine derivatives, the present inventors have discovered a benzo[a]cofenazine-6-carboxamide derivative that exhibits excellent antitumor activity and have completed the present invention. .
本発明は一般式11
[式中、R’は水素原子、ハロゲン原子、メチル基、水
酸基またはアルコキシ基を示し、R1は式、
−COOR’
(式中、RMは水素原子、直鎖もしくは分枝鎖のアルキ
ル基、シクロアルキル基、ベンジル基またはフェニル基
を示す。)または式、
(式中、R″およびR7は同一もしくは異なって水素原
子、低級アルキル基または互いに結合して隣接する窒素
原子と共に複素環を形成する基を示す、)で表わされる
基を示し、R”およびR4は同一もしくは異なって水素
原子または低級アルキル基を示し、nは2または3を示
す。コで表わされる新規ベンゾ[α]フェナジンー6−
カルポキサミド誘導体(以下、化合物Iと称する)に関
する。The present invention relates to the general formula 11 [wherein R' represents a hydrogen atom, a halogen atom, a methyl group, a hydroxyl group, or an alkoxy group, and R1 is the formula, -COOR' (wherein RM is a hydrogen atom, a straight chain or a branched chain alkyl group, cycloalkyl group, benzyl group or phenyl group) or the formula, (wherein R'' and R7 are the same or different and are a hydrogen atom, a lower alkyl group, or bonded to each other and together with an adjacent nitrogen atom) ) represents a group forming a heterocycle, R'' and R4 are the same or different and represent a hydrogen atom or a lower alkyl group, and n represents 2 or 3. A new benzo[α]phenazine-6-
The present invention relates to a carpoxamide derivative (hereinafter referred to as compound I).
本発明におけるハロゲン原子とは、フッ素、塩 ′素、
臭素またはヨウ素であり、アルコキシ基とは、メトキシ
基、エトキシ基、プロポキシ基、ブトキシ基などの低級
アルコキシ基などである。直鎖もしくは分枝鎖のアルキ
ル基とは、炭素原子数1〜20個のアルキル基であり、
たとえばメチル基、エチル基、プロピル基、イソプロピ
ル基、ブチル基、イソブチル基、ペンチル基、ネオペン
チル基、ヘキシル基、デシル基、エイフシル基などであ
る。シクロアルキル基とは、炭素原子数3〜6個のシク
ロアルキル基であり、たとえばシクロプロピル基、シク
ロペンチル基、シクロヘキシル基などである。低級アル
キル基とは、メチル基、エチル基、プロピル基、ブチル
基などのアルキル基である。In the present invention, halogen atoms include fluorine, chlorine,
It is bromine or iodine, and the alkoxy group includes lower alkoxy groups such as methoxy, ethoxy, propoxy, and butoxy groups. A straight chain or branched alkyl group is an alkyl group having 1 to 20 carbon atoms,
Examples include methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, pentyl group, neopentyl group, hexyl group, decyl group, eifcyl group, and the like. The cycloalkyl group is a cycloalkyl group having 3 to 6 carbon atoms, such as a cyclopropyl group, a cyclopentyl group, and a cyclohexyl group. The lower alkyl group is an alkyl group such as a methyl group, an ethyl group, a propyl group, a butyl group, and the like.
一般式Iで示されるベンゾ[aコフェナジン−6−カル
ボキサミド誘導体は新規な化合物であり、公知のエチル
3−ヒドロキシ−1,4−ジヒドロ−1゜4−ジオキ
ソ−2−ナフトニートから下記反応式に従い製造するこ
とができる(式中、R’# R”tR’、R’およびn
は前記の通りである)。The benzo[a-cofenazine-6-carboxamide derivative represented by the general formula I is a new compound, and is prepared from the known ethyl 3-hydroxy-1,4-dihydro-1°4-dioxo-2-naphtonite according to the following reaction formula. (wherein R'#R"tR', R' and n
is as described above).
■
すなわち、公知のエチル3−ヒドロキシ−1,4−シヒ
ドロー1.4−ジオキソ−2−ナフトニートを無水テト
ラヒドロフラン、N、N−ジメチルホルムアミド、ジオ
キサンなどの有機溶媒中、N、N’−カルボニルジイミ
ダゾールまたは塩化アセチル、塩化ピバロイルなどの塩
化アシルまたはクロルギ酸エチル、クロルギ酸ベンジル
などのクロルギ酸エステルで処理したのち、式■で示さ
れるフェニレンジアミン類を縮合きせることにより、式
■で示される複素環化合物を得ることができる。(2) Namely, known ethyl 3-hydroxy-1,4-sihydro-1,4-dioxo-2-naphtonite was mixed with N,N'-carbonyldiimidazole in an organic solvent such as anhydrous tetrahydrofuran, N,N-dimethylformamide, and dioxane. Or, by treating with an acyl chloride such as acetyl chloride or pivaloyl chloride or a chloroformic acid ester such as ethyl chloroformate or benzyl chloroformate, and then condensing phenylenediamines represented by the formula ■, a heterocyclic compound represented by the formula ■ can be obtained.
塩化アシルまたはクロルギ酸エステルで処理するときに
は、トリエチルアミンまたはピリジンなどの塩基触媒を
用いるのがよい。When treating with acyl chlorides or chloroformates, it is preferred to use a basic catalyst such as triethylamine or pyridine.
式Iで示されるフェニレンジアミン類はそれ自体公知で
あるか、または公知の化合物から公知の方法により得る
ことができる。後者の場合、たとえば5−アセチルアミ
ノサリチル酸をエステル化し、ニトロ化し、次いで脱ア
セチル化したのちニトロ基を還元するなどの方法により
フェニレンジアミン類を得ることができる。ここで得ら
れるフェニレンジアミン類は、場合により単離せずに゛
上記縮合反応に用いるのが好適である。The phenylenediamines of the formula I are known per se or can be obtained from known compounds by known methods. In the latter case, phenylenediamines can be obtained by, for example, esterifying 5-acetylaminosalicylic acid, nitrating it, then deacetylating it, and then reducing the nitro group. The phenylene diamines obtained here are preferably used in the above condensation reaction without being isolated as the case may be.
化合物■は式■で示される中間体を弐■で示される公知
のアルキルアミン類と縮合することにより得られる。こ
の縮合反応は、たとえばベンゼン、トルエン、N、N−
ジメチルホルムアミド、エタノール、ジクロルメタン、
テトラヒドロフランなどの有機溶媒中、または無溶媒で
行なわれる。反応温度は10〜120°C1好、ましく
は15〜30°Cである6反応に長時間を要する場合は
温度を高くするか、またはナトリウムアルフキシトのよ
うなアルカリ触媒を加えることにより反応時間を短縮す
ることができる。Compound (1) can be obtained by condensing the intermediate represented by formula (2) with a known alkylamine represented by (2). This condensation reaction can be carried out using, for example, benzene, toluene, N, N-
dimethylformamide, ethanol, dichloromethane,
It is carried out in an organic solvent such as tetrahydrofuran or without a solvent. The reaction temperature is 10 to 120°C, preferably 15 to 30°C. 6 If the reaction requires a long time, increase the temperature or add an alkali catalyst such as sodium alfuxite to increase the reaction time. can be shortened.
このようにして製造きれた化合物■は、以下の方法によ
ってR8を変換することができる。In the compound (1) thus produced, R8 can be converted by the following method.
すなわち、R8がカルボキシル基である化合物■を、た
とえばジアゾメタン、ジアゾエタンなどを用いてエステ
ル化することにより対応するエステルを得ることができ
る。That is, the corresponding ester can be obtained by esterifying the compound (1) in which R8 is a carboxyl group using, for example, diazomethane or diazoethane.
R1がアルフキジカルボニル基である化合物■を、アル
コール中、硫酸、パラトルエンスルホン酸などの酸触媒
下でエステル交換することにより、溶媒のアルコキシ基
が導入された対応するエステルを得ることができる。By transesterifying the compound (1) in which R1 is an alfkoxydicarbonyl group in an alcohol under an acid catalyst such as sulfuric acid or para-toluenesulfonic acid, a corresponding ester into which a solvent alkoxy group has been introduced can be obtained.
またR1がプルフキジカルボニル基である化合物Iを、
水、アルコール、N、N−ジメチルホルムアミド、ジメ
チルスルホキシドなどの溶媒中、またはこれらの混合溶
媒中アルカリ加水分解することにより対応するカルボン
酸を得ることができる。In addition, the compound I in which R1 is a purfukidicarbonyl group,
The corresponding carboxylic acid can be obtained by alkaline hydrolysis in a solvent such as water, alcohol, N,N-dimethylformamide, dimethyl sulfoxide, or a mixed solvent thereof.
更にR8がアルフキジカルボニル基である化合物■を、
ジオキサン、クロロホルムなどの有機溶媒中または無溶
媒で、常圧または加圧下にアンモニア、1級アミンを用
いてアミツリシスすることにより対応するカルボキサミ
ドを得ることができる。Furthermore, a compound (■) in which R8 is an alfkhidicarbonyl group,
The corresponding carboxamide can be obtained by amitulysis using ammonia or a primary amine in an organic solvent such as dioxane or chloroform or without a solvent at normal pressure or under increased pressure.
表−1に本発明によって得られる代表的な化合物Iを示
した。Table 1 shows typical compounds I obtained by the present invention.
見m米
本発明に係る一般式!で示される新規ベンゾ[αコフェ
ナジンー6−カルボキサミド誘導体は、各種担癌マウス
に対し強い延命効果を示した。また、従来の制癌剤で十
分な効果の認められない癌の治療および薬剤耐性の問題
の解決を可能とするものである。Take a look at the general formula related to the present invention! The novel benzo[alpha-cofenazine-6-carboxamide derivative shown in the following shows a strong survival effect on various tumor-bearing mice. It also makes it possible to treat cancers for which conventional anticancer drugs are not sufficiently effective and to solve the problem of drug resistance.
火夏忽
次に、参考例、実施例および試験例を示し、本発明を更
に詳細に説明する。Next, the present invention will be explained in more detail by showing reference examples, working examples, and test examples.
参考例1
エチル 5−アセチルアミノ−2−エトキシベンゾエー
トの製造
5−アセチルアミノサリチル酸20g5 ヨウ化エチル
41m11.無水炭酸カリウム50.5gをアセトン3
00m1lに加え、24時間還流した。冷後不溶物を濾
別、濾液を減圧下に乾固し、残渣をエーテルより再結晶
して表題の化合物を得た。Reference Example 1 Production of ethyl 5-acetylamino-2-ethoxybenzoate 5-acetylaminosalicylic acid 20g5 Ethyl iodide 41ml11. 50.5 g of anhydrous potassium carbonate in 3 parts of acetone
00ml and refluxed for 24 hours. After cooling, insoluble materials were filtered off, the filtrate was dried under reduced pressure, and the residue was recrystallized from ether to obtain the title compound.
m、p、 78〜79℃ 収量13.68g参考例2
エチル 5−アセチルアミノ−2−エトキシ−4−ニト
ロベンゾエートの製造
エチル 5−アセチルアミノ−2−エトキシベンジェ−
ト13.06gを無水酢酸50憾に懸濁し、発煙硝酸3
mlを水冷下に滴下した0滴下終了後、水冷下で30分
、室温で4時間攪拌した。反応液を氷水中に注ぎ析出し
た結晶を濾取し、エタノールより再結晶して表題の化合
物を得た。m, p, 78-79°C Yield 13.68g Reference Example 2 Production of ethyl 5-acetylamino-2-ethoxy-4-nitrobenzoate Ethyl 5-acetylamino-2-ethoxybenzoate
Suspend 13.06 g of nitric acid in 50 parts of acetic anhydride, and add 3 parts of fuming nitric acid.
ml was added dropwise while cooling with water. After completion of the dropwise addition, the mixture was stirred for 30 minutes under water cooling and for 4 hours at room temperature. The reaction solution was poured into ice water, and the precipitated crystals were collected by filtration and recrystallized from ethanol to obtain the title compound.
叱p、 118〜120℃ 収量6.35g参考例3
メチル 5−アミノ−2−エトキシ−4−ニトロベンゾ
エートの製造
エチル 5−アセチルアミノ−2−エトキシ−4−ニト
ロベンゾエート1.5gを5%硫酸−メタノール(V/
V)50ynllに懸濁し、4時間還流した。冷後、反
応液を氷水に注ぎ析出した結晶を濾取し、メタノールよ
り再結晶して表題の化合物を得た。118-120°C Yield 6.35g Reference Example 3 Production of methyl 5-amino-2-ethoxy-4-nitrobenzoate 1.5g of ethyl 5-acetylamino-2-ethoxy-4-nitrobenzoate was dissolved in 5% sulfuric acid. -methanol (V/
V) Suspended in 50ynll and refluxed for 4 hours. After cooling, the reaction solution was poured into ice water, and the precipitated crystals were collected by filtration and recrystallized from methanol to obtain the title compound.
ff1.I)、 156〜157℃ 収量1.01g参
考例4
エチル 10−エトキシ−5−ヒドロキシ−9−メトキ
シカルボニルベンゾ
キシレートの製造
(1)メチル 5−アミノ−2−エトキシ−4−ニトロ
ベンゾエート873mgおよび10%パラジウム−次素
50mgをエタノール50mlに懸濁し、室温下、常圧
で水素添加した。触媒を濾別し、濾液を,減圧下に乾固
して粗メチル 4.5−ジアミノ−2−エトキシベンゾ
エートを得た。ff1. I), 156-157°C Yield 1.01g Reference Example 4 Production of ethyl 10-ethoxy-5-hydroxy-9-methoxycarbonylbenzoxylate (1) Methyl 5-amino-2-ethoxy-4-nitrobenzoate 873mg and 50 mg of 10% palladium-hydrogen was suspended in 50 ml of ethanol, and hydrogenated at room temperature and normal pressure. The catalyst was filtered off, and the filtrate was dried under reduced pressure to obtain crude methyl 4,5-diamino-2-ethoxybenzoate.
(2)エチル 3−ヒドロキシ−1.4−ジヒドロ−1
。(2) Ethyl 3-hydroxy-1,4-dihydro-1
.
4−ジオキソ−2−ナフトニート895mgをN.N−
ジメチルホルムアミド10mlに溶解し、N.N″−カ
ルボニルジイミダゾール620mgを加え、室温下に2
時間攪拌した。これに上記(1)で得た粗メチル 4.
5−ジアミノ−2−エトキシベンゾエートの10tdN
.N−ジメチルホルムアミド溶液を水冷下に加え、室温
で一夜攪拌した。反応液にエタノール200mQを加え
、析出した結晶を濾取し、クロロホルム−エタノールよ
り再結晶して表題の化合物を得た。895 mg of 4-dioxo-2-naphtonite was added to N. N-
Dissolved in 10 ml of dimethylformamide, N. Add 620 mg of N″-carbonyldiimidazole and let the mixture cool for 2 hours at room temperature.
Stir for hours. Add to this the crude methyl obtained in (1) above 4.
10tdN of 5-diamino-2-ethoxybenzoate
.. A N-dimethylformamide solution was added under water cooling, and the mixture was stirred at room temperature overnight. 200 mQ of ethanol was added to the reaction solution, and the precipitated crystals were collected by filtration and recrystallized from chloroform-ethanol to obtain the title compound.
m.p. 270 〜273℃ 収量531mg対応す
るヨウ化アルキルを用い、参考例1と同様に処理して以
下の化合物を得た。m. p. 270-273°C Yield: 531 mg Using the corresponding alkyl iodide, the following compound was obtained by treating in the same manner as in Reference Example 1.
参考例5
プロピル 5−アセチルアミノ−2−プロポキシベンゾ
エート
油状物質
参考例6
ブチル 5−アセチルアミノ−2−ブトキシベンゾエー
ト
油状物質
対応するアセチルアミノベンジェ−トラ用イ、参考例2
と同様に処理して、以下の化合物を得た。Reference example 5 Propyl 5-acetylamino-2-propoxybenzoate oily substance Reference example 6 Butyl 5-acetylamino-2-butoxybenzoate oily substance For corresponding acetylaminobenjetra A, Reference example 2
The following compound was obtained by treatment in the same manner as above.
参考例7
プロピル 5−アセチルアミノ−4−ニトロ−2−プロ
ポキシベンゾエート
m.p. 89〜91℃
参考例8
ブチル 5−アセチルアミノ−2−ブトキシ−4−ニト
ロベンゾエート
m.p. 82〜83℃
参考例9
メチル 4−アセチルアミノ−2−ヒドロキシ−5−ニ
トロベンゾエート
ff1.p. 171〜11℃
参考例10
メチル 4−アセチルアミノ−2−クロロ−5−ニトロ
ベンゾエート
m.p. 132.5.〜134. 0℃参考例2.参
考例7,参考例8,参考例9または参考例10で得たア
セチルアミノニトロベンゾエートのそれぞれについて、
種々のアルコールを用い、参考例3と同様に処理し、以
下の化合物を得た。Reference Example 7 Propyl 5-acetylamino-4-nitro-2-propoxybenzoate m. p. 89-91°C Reference Example 8 Butyl 5-acetylamino-2-butoxy-4-nitrobenzoate m. p. 82-83°C Reference Example 9 Methyl 4-acetylamino-2-hydroxy-5-nitrobenzoate ff1. p. 171-11°C Reference Example 10 Methyl 4-acetylamino-2-chloro-5-nitrobenzoate m. p. 132.5. ~134. 0°C reference example 2. For each of the acetylaminonitrobenzoate obtained in Reference Example 7, Reference Example 8, Reference Example 9 or Reference Example 10,
The following compounds were obtained by treating in the same manner as in Reference Example 3 using various alcohols.
参考例11
エチル 5−アミノ−2−エトキシ−4−ニトロベンシ
ェード
m、p、 140〜141℃
参考例12
ブチル 5−アミノ−2−エトキシ−4−ニトロベンゾ
エート
m、p、 90〜92℃
参考例13
メチル 5−アミノ−4−ニトロ−2−プロポキシベン
ゾエート
m、p、 132〜134℃
参考例14
エチル 5−アミノ−4−ニトロ−2−プロポキシベン
ゾエート
111、p、 101〜102℃
参考例15
プロピル 5−アミノ−4−ニトロ−2−プロポキシベ
ンゾエート
m、p、 105〜106℃
参考例16
ブチル 5−アミノ−4−ニトロ−2−プロポキシベン
ゾエート
m、p、 72〜75℃
参考例17
メチル 5−アミノ−2−ブトキシ−4−ニトロベンゾ
エート
m、p、 121〜122°C
参考例18
ブチル 5−アミノ−2−ブトキシ−4−ニトロベンゾ
エート
m、p、 67〜68°C
参考例19
メチル 4−アミノ−2−ヒドロキシ−5−ニトロベン
ゾエート
tll、p、 197〜199℃
参考例20
メチル 5−アミノ−2−クロロ−4−エトロペンゾ工
−ト
m、p、 225〜226°C
参考例21
5−アミノ−2−メトキシ−4−ニトロ安息香酸の製造
メチル 5−アミノ−2−メトキシ−4−二トロペンゾ
エート13.57gをジオキサン250m1に懸濁し、
水酸化カリウム4.36 gと水25m1の溶液を加え
て4時間還流した0次いで反応液に濃塩酸7m1lを加
え、減圧下に溶媒を留去し、残渣にジオキサンを加え1
時間還流した。不溶物を濾別し、濾液から析出した表題
化合物の結晶を得た。Reference example 11 Ethyl 5-amino-2-ethoxy-4-nitrobenshade m, p, 140-141°C Reference example 12 Butyl 5-amino-2-ethoxy-4-nitrobenzoate m, p, 90-92°C Reference Example 13 Methyl 5-amino-4-nitro-2-propoxybenzoate m, p, 132-134°C Reference example 14 Ethyl 5-amino-4-nitro-2-propoxybenzoate 111, p, 101-102°C Reference example 15 Propyl 5-amino-4-nitro-2-propoxybenzoate m, p, 105-106°C Reference example 16 Butyl 5-amino-4-nitro-2-propoxybenzoate m, p, 72-75°C Reference example 17 Methyl 5 -Amino-2-butoxy-4-nitrobenzoate m, p, 121-122°C Reference example 18 Butyl 5-amino-2-butoxy-4-nitrobenzoate m, p, 67-68°C Reference example 19 Methyl 4 -Amino-2-hydroxy-5-nitrobenzoate tll, p, 197-199°C Reference example 20 Methyl 5-amino-2-chloro-4-etropenzoate m, p, 225-226°C Reference example 21 5 -Production of amino-2-methoxy-4-nitrobenzoic acid 13.57 g of methyl 5-amino-2-methoxy-4-nitrobenzoate was suspended in 250 ml of dioxane,
A solution of 4.36 g of potassium hydroxide and 25 ml of water was added and refluxed for 4 hours.Next, 7 ml of concentrated hydrochloric acid was added to the reaction mixture, the solvent was distilled off under reduced pressure, and dioxane was added to the residue.
Refluxed for an hour. Insoluble matter was filtered off to obtain crystals of the title compound precipitated from the filtrate.
m、 p、 252〜255℃ 収量10.99g参考
例22
1−(5−アミノ−2−メトキシ−4−ニトロベンゾイ
ル)ピロリジンの製造
5−アミノ−2−メトキシ−4−ニトロ安息香酸4.2
4gをN、N−ジメチルホルムアミド30m1lに溶解
し、N、N’−カルボニルジイミダゾール3.24gを
室温下に加えた。30分後にピロリジン5m1lを加え
、2時間攪拌を続けた。減圧下に溶媒を留去し、残渣を
酢酸エチルより再結晶して表題の化合物を得た。m, p, 252-255°C Yield 10.99g Reference Example 22 Production of 1-(5-amino-2-methoxy-4-nitrobenzoyl)pyrrolidine 5-amino-2-methoxy-4-nitrobenzoic acid 4.2
4 g was dissolved in 30 ml of N,N-dimethylformamide, and 3.24 g of N,N'-carbonyldiimidazole was added at room temperature. After 30 minutes, 5 ml of pyrrolidine was added and stirring was continued for 2 hours. The solvent was distilled off under reduced pressure, and the residue was recrystallized from ethyl acetate to obtain the title compound.
m、p、 159〜162℃ 収量4.16gピロリジ
ンに代えてジメチルアミンまたはネオペンチルアルコー
ルを用い、参考例22と同様に処理して以下の化合物を
得た。m, p, 159-162°C Yield: 4.16g The following compound was obtained by using dimethylamine or neopentyl alcohol in place of pyrrolidine and treating in the same manner as in Reference Example 22.
参考例23
N、N−ジメチル 5−アミノ−2−メトキシ−4−ニ
トロベンズアミド
m、p、 209〜211℃
参考例24
ネオペンチル 5−アミノ−2−メトキシ−4−ニトロ
ベンゾエート
m、p、 173〜177℃
参考例25
5−アミノ−2−メトキシ−4−ニトロベンズアミドの
製造
メチル 5−アミノ−2−メトキシ−4−ニトロベンゾ
エート5.66gをジオキサン200m1に溶解し、2
8%アンモニア水50m1を加えて室温下に40時間放
置した。減圧下に溶媒を留去し、残渣をジオキサンより
再結晶して表題の化合物を得た。Reference example 23 N,N-dimethyl 5-amino-2-methoxy-4-nitrobenzamide m, p, 209-211°C Reference example 24 Neopentyl 5-amino-2-methoxy-4-nitrobenzoate m, p, 173- 177°C Reference Example 25 Production of 5-amino-2-methoxy-4-nitrobenzamide Methyl 5.66 g of 5-amino-2-methoxy-4-nitrobenzoate was dissolved in 200 ml of dioxane,
50 ml of 8% aqueous ammonia was added and left at room temperature for 40 hours. The solvent was distilled off under reduced pressure, and the residue was recrystallized from dioxane to obtain the title compound.
m、p、 250〜257℃ 収量4.30g参考例2
6
N−エチル 5−アミノ−2−メトキシ−4−ニトロベ
ンズアミドの製造
70%エチルアミン水溶液を用い、参考例25と同様に
処理して得た。m, p, 250-257℃ Yield 4.30g Reference Example 2
Preparation of 6 N-ethyl 5-amino-2-methoxy-4-nitrobenzamide It was obtained in the same manner as in Reference Example 25 using a 70% aqueous ethylamine solution.
m、p、 235〜239℃
参考例27
フェニル 5−アミノ−2−メトキシ−4−ニトロベン
ゾエートの製造
5−アミノ−2−メトキシ−4−ニトロ安息香酸5.5
5gをベンゼン40m1に懸濁し、塩化チオニル40m
1を加えて4時間還流した。次いで過剰の塩化チオニル
および溶媒を留去し、残渣をベンゼン40mQに溶解し
てフェノール12.3gおよびトリエチルアミン15、
3mQを水冷下に加え、水冷下30分、室温で一夜攪拌
した。反応液に水および酢酸エチルを加え、有機層を1
0%水酸化ナトリウム水、次いで水で洗った後、減圧下
に溶媒を留去した。残渣をシリカゲルカラムクロマトグ
ラフィーにイオし、ベンゼン溶出画分を集め、メタノー
ルより再結晶して表題の化合物を得た。m, p, 235-239°C Reference Example 27 Production of phenyl 5-amino-2-methoxy-4-nitrobenzoate 5-amino-2-methoxy-4-nitrobenzoic acid 5.5
Suspend 5g in 40ml of benzene, add 40ml of thionyl chloride
1 was added and the mixture was refluxed for 4 hours. Next, excess thionyl chloride and the solvent were distilled off, and the residue was dissolved in 40 mQ of benzene to obtain 12.3 g of phenol, 15 g of triethylamine,
3 mQ was added under water cooling, and the mixture was stirred under water cooling for 30 minutes and at room temperature overnight. Water and ethyl acetate were added to the reaction solution, and the organic layer was diluted with 1
After washing with 0% aqueous sodium hydroxide and then with water, the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and the benzene eluted fractions were collected and recrystallized from methanol to obtain the title compound.
m、p、 130〜132℃ 収量2.55g参考例4
と同様に、メチル 5−アミノ−2−エトキシ−4−ニ
トロベンゾエートに代えて対応する5−アミノ−4−ニ
トロ安息香酸エステルを用い、それぞれ以下の式■で示
きれる中間体を得た。m, p, 130-132°C Yield 2.55g Reference Example 4
Similarly, by replacing methyl 5-amino-2-ethoxy-4-nitrobenzoate with the corresponding 5-amino-4-nitrobenzoic acid ester, intermediates represented by the following formula (1) were obtained.
参考例28
工f)し 10−エトキシ−9−エトキシカルボニル−
5−ヒドロキシベンゾ[(Z]フェナジン−6−カルボ
キシレート
m、p、160〜162℃
参考例29
エチル 9−ブトキシカルボニル−10−エトキシ−5
−ヒドロキシベンゾ[α]フェナジンー6−カルボキシ
レート
m、p、 122.5〜123.5℃
参考例30
エチル 5−ヒドロキシ−9−メトキシカルボニル−1
0−プロポキシベンゾ[(21フェナジン−6−カルボ
キシレート
m、p、 143〜145℃
参考例31
エチル 9−エトキシカルボニル−5−ヒドロキシ−1
0−プロポキシベンゾ[αコフエナジンー6−カルボキ
シレート
ff1.り、 117〜119℃
参考例32
エチル 5−ヒドロキシ−10−プロポキシ−9−プロ
ポキシカJレボニルベンゾ[α]フェナジン−6−カル
ボキシレート
m、p、 153〜155℃
参考例33
エチル 9−ブトキシカルボニル−
−10−プロポキシベンゾ[a]フェナジン−6−カル
ボキシレート
m.p. 119〜120℃
参考例34
エチル 10−ブトキシ−5−ヒドロキシ−9−メトキ
シカルボニル−ベンゾ
ボキシレート
m.p. 143〜144℃
参考例35
エチル 10−ブトキシ−9−ブトキシカルボニル−5
−ヒドロキシベンゾ[αコフェナジン−6−カルボキシ
レート
m.p. 122〜124℃
参考例36
エチル 5−ヒドロキシ−9−メトキシカルボニル−1
0−メチルベンゾ[αコフェナジンー6ーカルボキシレ
ート
ffi.p. 295〜299℃
参考例37
エチル 5.10−ジヒドロキシ−9−メトキシカルボ
ニルベンゾ[(Zコフエナジン−6−カルボキシレート
の製造
メチル 5−アミノ−2−エトキシ−4−ニトロベンゾ
エートに代えてメチル 4−アミノ−2−ヒドロキシ−
5−ニトロベンゾエートを用い、参考例4と同様に処理
して得た。Reference example 28 f) 10-ethoxy-9-ethoxycarbonyl-
5-Hydroxybenzo[(Z]phenazine-6-carboxylate m, p, 160-162°C Reference Example 29 Ethyl 9-butoxycarbonyl-10-ethoxy-5
-Hydroxybenzo[α]phenazine-6-carboxylate m, p, 122.5-123.5°C Reference Example 30 Ethyl 5-hydroxy-9-methoxycarbonyl-1
0-Propoxybenzo[(21 phenazine-6-carboxylate m, p, 143-145°C Reference Example 31 Ethyl 9-ethoxycarbonyl-5-hydroxy-1
0-propoxybenzo[αcohuenazine-6-carboxylate ff1. 117-119°C Reference Example 32 Ethyl 5-hydroxy-10-propoxy-9-propoxycarbonylbenzo[α]phenazine-6-carboxylate m, p, 153-155°C Reference Example 33 Ethyl 9-butoxycarbonyl - 10-propoxybenzo[a]phenazine-6-carboxylate m. p. 119-120°C Reference Example 34 Ethyl 10-butoxy-5-hydroxy-9-methoxycarbonyl-benzoboxylate m. p. 143-144°C Reference Example 35 Ethyl 10-butoxy-9-butoxycarbonyl-5
-Hydroxybenzo[α-cofenazine-6-carboxylate m. p. 122-124°C Reference Example 36 Ethyl 5-hydroxy-9-methoxycarbonyl-1
0-Methylbenzo[α-cofenazine-6-carboxylateffi. p. 295-299°C Reference Example 37 Ethyl 5.10-dihydroxy-9-methoxycarbonylbenzo[(Z Production of cofenadine-6-carboxylate Methyl 5-amino-2-ethoxy-4-nitrobenzoate replaced with methyl 4-amino -2-hydroxy-
It was obtained in the same manner as in Reference Example 4 using 5-nitrobenzoate.
m、p、 300℃以上
参考例3B
エチル 9−エトキシカルボニル−
ベンゾ[αコフェナジンー6ーカルボキシレートの製造
メチル 5−アミノ−2−エトキシ−4−ニトロベンゾ
エートに代えてエチル 4−アミノ−3ニトロベンゾエ
ートを用い、参考例4と同様に処理して得た。 m.p
. 210〜213℃
参考例39
エチル 5−ヒドロキシ−10−メトキシ−9−フェノ
キシカルボニルベンゾ[ミコフェナジン−6−カルボキ
シレートの製造
メチル 5−アミノ−2−エトキシ−4−ニトロベンゾ
エートに代えてフェニル 5−アミノ−2−メトキシ−
4−ニトロベンゾエートを用い、参考例4と同様に処理
して得た。m, p, 300°C or higher Reference Example 3B Ethyl 9-ethoxycarbonyl-benzo[α Production of cofenazine-6-carboxylate Methyl 5-amino-2-ethoxy-4-nitrobenzoate replaced with ethyl 4-amino-3-nitrobenzoate It was obtained by processing in the same manner as in Reference Example 4. m. p
.. 210-213°C Reference Example 39 Ethyl 5-Hydroxy-10-methoxy-9-phenoxycarbonylbenzo[Mycofenazine-6-carboxylate Production Methyl 5-amino-2-ethoxy-4-nitrobenzoate Phenyl 5- Amino-2-methoxy-
It was obtained in the same manner as in Reference Example 4 using 4-nitrobenzoate.
m.2. 171〜173℃
参考例40
エチル 10−クロロ−5−ヒドロキシ−9−メトキシ
カルボニルベンゾ
シレートの製造
メチル 5−アミノ−2−クロロ−4−エトロペンゾ工
−トをエタノール中、鉄−塩酸で還元して粗メチル 4
、 5−ジアミノ−2−クロロペンゾエートヲ得、以
下参考例4(2)と同様に処理して得た。m. 2. 171-173°C Reference Example 40 Production of ethyl 10-chloro-5-hydroxy-9-methoxycarbonylbenzosylate Methyl 5-amino-2-chloro-4-etropenzoate was reduced with iron-hydrochloric acid in ethanol. crude methyl 4
, 5-diamino-2-chloropenzoate was obtained by the same treatment as in Reference Example 4(2).
m.p. 225〜226℃
参考例41
エチル 9−カッしホキシー5−ヒドロキシベンゾ[α
]フェナジン−6−カルボキシレートの製造メチル 4
.5−ジアミノ−2−エトキシベンゾエートに代えて3
.4−ジアミノ安息香酸を用い、参考例4(2)と同様
に処理して得た。m. p. 225-226℃ Reference Example 41 Ethyl 9-katoxy5-hydroxybenzo[α
] Production of phenazine-6-carboxylate Methyl 4
.. 3 instead of 5-diamino-2-ethoxybenzoate
.. It was obtained in the same manner as in Reference Example 4(2) using 4-diaminobenzoic acid.
m.p. 300℃以上
参考例42
4、5−ジアミノ−2−メトキシベンズアミドの製造
5−アミノ−2−メトキシ−4−ニトロベンズアミド3
. 04gおよび10%パラジウム−炭素110mgを
メタノール300mlに懸濁し、常圧、60℃で水素添
加した。触媒を濾別、濾液を濃縮し、表題化合物の結晶
を得た。m. p. 300°C or higher Reference Example 42 Production of 4,5-diamino-2-methoxybenzamide 5-amino-2-methoxy-4-nitrobenzamide 3
.. 04g and 110mg of 10% palladium-carbon were suspended in 300ml of methanol and hydrogenated at normal pressure and 60°C. The catalyst was filtered off, and the filtrate was concentrated to obtain crystals of the title compound.
m.p. 181〜183℃ 収量2.18g参考例4
3
N−エチル 4.5−ジアミノ−2−メトキシベンズア
ミドの製造
N−エチル 5−アミノ−2−メトキシ−4−ニトロベ
ンズアミドを参考例42と同様に処理して得た。m. p. 181-183℃ Yield 2.18g Reference Example 4
3 Preparation of N-ethyl 4.5-diamino-2-methoxybenzamide N-ethyl 5-amino-2-methoxy-4-nitrobenzamide was obtained in the same manner as in Reference Example 42.
m.p. 65〜67℃
参考例44
エチル 5−ヒドロキシ−10−メトキシ−9−メトキ
シカルボニルベンゾ[αコフエナジン−6−カルポキシ
レートの製造
(1)エチル 3−ヒドロキシ−1.4−ジヒドロ−1
、4−ジオキソ−2−ナフトニート2. 48gおよび
トリエチルアミン1.5mlを無水テトラヒドロフラン
10mlに溶解し、クロルギ酸エチル1賊を5℃以下で
滴下し、室温で2時間攪拌した。生成した固形物を濾別
し、濾液を減圧下に乾固し、粗エチル3ーエトキシカル
ボニルオキシ−1.4−ジヒドロ−1、4−ジオキソ−
2−ナフトニートを得た。m. p. 65-67°C Reference Example 44 Ethyl 5-hydroxy-10-methoxy-9-methoxycarbonylbenzo[α Production of cofenadine-6-carpoxylate (1) Ethyl 3-hydroxy-1.4-dihydro-1
, 4-dioxo-2-naphthonito2. 48 g and 1.5 ml of triethylamine were dissolved in 10 ml of anhydrous tetrahydrofuran, one portion of ethyl chloroformate was added dropwise at below 5° C., and the mixture was stirred at room temperature for 2 hours. The produced solid was filtered off, and the filtrate was dried under reduced pressure to give crude ethyl 3-ethoxycarbonyloxy-1,4-dihydro-1,4-dioxo-
2-naphtonite was obtained.
(2)メチル 4.5−ジアミノ−2−メトキシベンゾ
エート2.16gをN.N−ジメチルホルムアミド7m
lに溶解し、上記(1)で得た粗エチル3ーエトキシカ
ルボニルオキシ−1.4−ジヒドロ−1.4−ジオキソ
−2−ナフトニートのN,N−ジメチルホルムアミド7
ynll溶液を水冷下に加え、2時間攪拌した.次いで
エタノール100mlを加えて析出した結晶を濾取し、
クロロホルム−エタノールより再結晶して表題の化合物
を得た。(2) 2.16 g of methyl 4.5-diamino-2-methoxybenzoate was added to N.I. N-dimethylformamide 7m
N,N-dimethylformamide 7 of the crude ethyl 3-ethoxycarbonyloxy-1,4-dihydro-1,4-dioxo-2-naphtonite obtained in (1) above, dissolved in
ynll solution was added under water cooling and stirred for 2 hours. Next, 100 ml of ethanol was added and the precipitated crystals were collected by filtration.
Recrystallization from chloroform-ethanol gave the title compound.
m.p. 202.5〜207℃ 収量3.66gメチ
ル 4.5−ジアミノ−2−メトキシベンゾエートに代
えて参考例42または参考例43で得たオルトフェニレ
ンジアミンを用い、参考例44と同様に処理して、それ
ぞれ以下の弐■で示きれる中間体を得た。m. p. 202.5-207°C Yield 3.66 g Methyl 4.5-Diamino-2-methoxybenzoate was replaced with orthophenylenediamine obtained in Reference Example 42 or Reference Example 43, and treated in the same manner as in Reference Example 44. Intermediates shown in the following 2) were obtained.
参考例45
エチル 9−カルバモイル−5−ヒドロキシ−10=メ
トキシベンゾ[a]フェナジン−6−カルボキシレート
m、p、 300℃以上
参考例46
エチル 9−エチルカルバモイル−
−10−メトキシベンゾ[(Z]フェナジン−6−カル
ボキシレート
m.p.190〜193℃
参考例47
エチル 5−ヒドロキシ−10−メトキシ−9−ジメチ
ルカルバモイルベンゾ
ボキシレートの製造
N.N−ジメチル 5−アミノ−2−メトキシ−4−二
トロペンズアミド3.62gおよび10%パラジウム−
炭素150mgをエタノール1 40mllに懸濁し、
常圧、70〜80°Cで水素添加した。触媒を濾別し、
濾液を減圧下に乾固して粗N.Nージメチル 4.5−
ジアミノ−2−メトキシベンズアミドを得、テトラヒド
ロフラン30rdに溶解した。Reference Example 45 Ethyl 9-carbamoyl-5-hydroxy-10=methoxybenzo[a]phenazine-6-carboxylate m, p, 300°C or higher Reference Example 46 Ethyl 9-ethylcarbamoyl-10-methoxybenzo[(Z] Phenazine-6-carboxylate m.p. 190-193°C Reference Example 47 Production of ethyl 5-hydroxy-10-methoxy-9-dimethylcarbamoylbenzoboxylate N.N-dimethyl 5-amino-2-methoxy-4 - 3.62 g of nitropenzamide and 10% palladium -
Suspend 150 mg of carbon in 140 ml of ethanol,
Hydrogenation was carried out at normal pressure and 70-80°C. Filter the catalyst,
The filtrate was dried under reduced pressure to obtain crude N. N-dimethyl 4.5-
Diamino-2-methoxybenzamide was obtained and dissolved in tetrahydrofuran 30rd.
別にエチル 3−ヒドロキシ−1.4−ジヒドロ−1、
4−ジオキソ−2−ナフトニート3.41gを参考例4
4(1)と同様に処理してエチル 3−エトキシカルボ
ニルオキシ−1.4−ジヒドロ−1.4−ジオキソ−2
−ナフトニートを得、テトラヒドロフラン10mllに
溶解し、水冷下に先に製造したN,N−ジメチル4、5
−ジアミノ−2−メトキシベンズアミドのテトラヒドロ
フラン溶液に加え、室温で2時間攪拌した。反応液にエ
タノール100mQを加支、析出した結晶を濾取し、ク
ロロホルム−エタノールより再結晶し表題の化合物を得
た。Separately ethyl 3-hydroxy-1,4-dihydro-1,
Reference Example 4: 3.41 g of 4-dioxo-2-naphtonite
4(1) to obtain ethyl 3-ethoxycarbonyloxy-1,4-dihydro-1,4-dioxo-2
-Naphtonite was obtained, dissolved in 10 ml of tetrahydrofuran, and cooled with water to obtain the previously prepared N,N-dimethyl 4,5
-Diamino-2-methoxybenzamide was added to a tetrahydrofuran solution, and the mixture was stirred at room temperature for 2 hours. 100 mQ of ethanol was added to the reaction solution, and the precipitated crystals were collected by filtration and recrystallized from chloroform-ethanol to obtain the title compound.
m.p. 224〜227℃ 収量3.70gN,N−
ジメチル 5−アミノ−2−メトキシ−4−ニトロベン
ズアミドに代えて対応するオルトニトロアニリンを用い
、参考例47と同様に処理して、それぞれ以下の式■で
示される中間体を得た。m. p. 224-227℃ Yield 3.70gN,N-
Dimethyl 5-amino-2-methoxy-4-nitrobenzamide was replaced with the corresponding orthonitroaniline and treated in the same manner as in Reference Example 47 to obtain intermediates represented by the following formula (1).
参考例4B
エチル 5−ヒドロキシ−10−メトキシ−9 −(
1 −ピロリジノカルボニル)ベンゾ[(Zlフェナジ
ン−6−カルボキシレート
m.p. 221〜224℃
参考例49
エチル 5−ヒドロキシ−10−メトキシ−9−ネオペ
ンチルオキシカルボニルベンゾ[(21フェナジン−6
−カルボキシレート
m.p. 153〜157℃
実施例I
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−メトキシカルボニルベンゾ[αコフェ
ナジン−6−カルボキサミドの製造エチル 5−ヒドロ
キシ−10−メトキシ−9−メトキシカルボニルベンゾ
[+2]フェナジン−6−カルボキシレート20.32
gをヘンゼン500mllに溶解し、N.N−ジメチル
エチレンジアミン11+nQを加えて2時間還流した。Reference Example 4B Ethyl 5-hydroxy-10-methoxy-9-(
1-pyrrolidinocarbonyl)benzo[(Zl phenazine-6-carboxylate m.p. 221-224°C Reference Example 49 Ethyl 5-hydroxy-10-methoxy-9-neopentyloxycarbonylbenzo[(21 phenazine-6
-carboxylate m. p. 153-157°C Example I N-β-dimethylaminoethyl 5-hydroxy-10
-Methoxy-9-methoxycarbonylbenzo[alpha] Production of cofenazine-6-carboxamide Ethyl 5-hydroxy-10-methoxy-9-methoxycarbonylbenzo[+2]phenazine-6-carboxylate 20.32
Dissolve N. g in 500 ml of Hensen. N-dimethylethylenediamine 11+nQ was added and the mixture was refluxed for 2 hours.
溶媒を減圧下に留去し、残渣をクロロホルム−エタノー
ルより再結晶して表題の化合物を得た。The solvent was distilled off under reduced pressure, and the residue was recrystallized from chloroform-ethanol to obtain the title compound.
m.p. 195〜196℃ 収量22. 17g対応
する式■で示される中間体を用い、実施例1と同様に処
理して以下の化合物Iを得た。m. p. 195-196℃ Yield 22. Using 17g of the corresponding intermediate represented by formula (2), the following compound I was obtained by processing in the same manner as in Example 1.
実施例2
N−β−ジメチルアミノエチル 5−ヒドロキシ−9−
カルボキシベンゾ[αコフエナジンー6ーカルポキサミ
ド
m.p. 245〜246℃
実施例3
N−β−ジメチルアミノエチル 9−エトキシカルボニ
ル−5−ヒドロキシベンゾ[α]フェナジンー6ーカル
ポキサミド
ffi.1)、 200〜204℃
実施例4
N−β−ジメチルアミノエチル 10−クロロ−5−ヒ
ドロキシ−9−メトキシカルボニルベンゾ[(Z]フェ
ナジン−6−カルボキサミド
ff1.p. 217〜221℃
実施例5
N−β−ジメチルアミノエチル 5−ヒドロキシ−9−
メトキシカルボニル−
フェナジン−6−カルボキサミド
m、p、 219〜220℃
実施例6
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−フェノキシカルボニルベンゾ[aコフ
エナジン−6−カルボキサミドm、p、 189〜19
0℃
実施例7
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−ネオペンチルオキシカルボニルベンゾ
[ミコフェナジン−6−カルトポキサミドm、p、 1
86〜188℃
実施例8
N−β−ジメチルアミノエチル 9−カルバモイル−5
−ヒドロキシ−10−メトキシベンゾ[aコフェナジン
−6−カルボキサミド
m、p、 234〜237℃
実施例9
N−β−ジメチルアミノエチル 9−エチルカルバモイ
ル−5−ヒドロキシ−10−メトキシベンゾ[ミコフェ
ナジン−6−カルボキサミド
ff14)、 230〜233℃
実施例1O
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−ジメチルカルバモイルベンゾ[ミコフ
ェナジン−6−カルボキサミド”、p. 202〜20
4℃
実施例11
N−β−ジメチルアミンエチル 5−ヒドロキシ−10
−メトキシ−9 −( 1−ピロリジノカルボニルンゾ
[α]フェナジンー6ーカルポキサミドm.p. 22
8〜230℃
実施例12
N−β−ジメチルアミンエチル 10−エトキシ−5−
ヒドロキシ−9−メトキシカルボニルベンゾ[α]フェ
ナジンー6ーカルポキサミド111、1)、 170〜
172℃
実施例13
N−β−ジメチルアミノエチル 10−エトキシ−9−
エトキシカルボニル−
[α]フェナジンー6ーカルポキサミドm.p. 15
8〜160℃
実施例14
N−β−ジメチルアミンエチル 9−ブトキシカルボニ
ル−10−エトキシ−5−ヒドロキシベンゾ[(Z]フ
ェナジン−6−カルボキサミド
m.p. 138 〜140℃
実施例15
N−β−ジメチルアミノエチル 5−ヒドロキシ−9−
メトキシカルボニル−
[α]フェナジンー6ーカルポキサミドm.p. 18
7〜188℃
実施例16
N−β−ジメチルアミノエチル 9−エトキシカルボニ
ル−5−ヒドロキシ−10−プロポキシベンゾ[(Z]
フェナジン−6−カルボキサミドm.p. 154〜1
55℃
実施例17
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−プロポキシ−9−プロポキシカルボニルベンゾ[αコ
フェナジンー6ーカルポキサミドff11. 114〜
115℃
実施例1B
N−β−ジメチルアミノエチル
ボニル5−ヒドロキシ−10−プロポキシベンゾ[(Z
]フェナジン−6−カルボキサミドm.p. 65〜6
6℃
実施例19
N−β−ジメチルアミノエチル 10−ブトキシ−5−
ヒドロキシ−9−メトキシカルボニルベンゾ[aコフエ
ナジン−6一カルボキサミドm.p. 171〜17
2℃
実施例2O
N−β−ジメチルアミノエチル 10−ブトキシ−9−
ブトキシカルボニル−
[aコフェナジン−6一カルボキサミドff11.
102〜104℃
実施例21
N−β−ジメチルアミノエチル 5,10−ジヒドロキ
シ−9−メトキシカルボニルベンゾジン−6−カルトポ
キサミド
m、p、 250℃(分解)
実施例22
N−β−エチルアミノエチル 5−ヒドロキシ−10−
メトキシ−9−メトキシカルボニルベンゾ[α]フェナ
ジン−6−カルポキサミドの製造
N、N−ジメチルエチレンジアミンに代えてN−エチル
エチレンジアミンを用い、実施例1と同様に処理して得
た。Example 2 N-β-dimethylaminoethyl 5-hydroxy-9-
Carboxybenzo[alpha cohuenazine-6-carpoxamide m. p. 245-246°C Example 3 N-β-dimethylaminoethyl 9-ethoxycarbonyl-5-hydroxybenzo[α]phenazine-6-carpoxamideffi. 1), 200-204°C Example 4 N-β-dimethylaminoethyl 10-chloro-5-hydroxy-9-methoxycarbonylbenzo[(Z]phenazine-6-carboxamide ff1.p. 217-221°C Example 5 N-β-dimethylaminoethyl 5-hydroxy-9-
Methoxycarbonyl-phenazine-6-carboxamide m, p, 219-220°C Example 6 N-β-dimethylaminoethyl 5-hydroxy-10
-methoxy-9-phenoxycarbonylbenzo[a cohuenazine-6-carboxamide m, p, 189-19
0°C Example 7 N-β-dimethylaminoethyl 5-hydroxy-10
-Methoxy-9-neopentyloxycarbonylbenzo[mycofenazine-6-cartopoxamide m, p, 1
86-188°C Example 8 N-β-dimethylaminoethyl 9-carbamoyl-5
-hydroxy-10-methoxybenzo[a cofenazine-6-carboxamide m, p, 234-237°C Example 9 N-β-dimethylaminoethyl 9-ethylcarbamoyl-5-hydroxy-10-methoxybenzo[mycofenazine-6 -carboxamide ff14), 230-233°C Example 1O N-β-dimethylaminoethyl 5-hydroxy-10
-Methoxy-9-dimethylcarbamoylbenzo[mycofenazine-6-carboxamide”, p. 202-20
4°C Example 11 N-β-dimethylamine ethyl 5-hydroxy-10
-Methoxy-9-(1-pyrrolidinocarbonylnzo[α]phenazine-6-carpoxamide m.p. 22
8-230°C Example 12 N-β-dimethylamine ethyl 10-ethoxy-5-
Hydroxy-9-methoxycarbonylbenzo[α]phenazine-6-carpoxamide 111, 1), 170~
172°C Example 13 N-β-dimethylaminoethyl 10-ethoxy-9-
Ethoxycarbonyl-[α]phenazine-6-carpoxamide m. p. 15
8 to 160°C Example 14 N-β-dimethylamine ethyl 9-butoxycarbonyl-10-ethoxy-5-hydroxybenzo[(Z]phenazine-6-carboxamide m.p. 138 to 140°C Example 15 N-β -dimethylaminoethyl 5-hydroxy-9-
Methoxycarbonyl-[α]phenazine-6-carpoxamide m. p. 18
7-188°C Example 16 N-β-dimethylaminoethyl 9-ethoxycarbonyl-5-hydroxy-10-propoxybenzo[(Z]
Phenazine-6-carboxamide m. p. 154-1
55°C Example 17 N-β-dimethylaminoethyl 5-hydroxy-10
-Propoxy-9-propoxycarbonylbenzo[α-cofenazine-6-carpoxamideff11. 114~
115°C Example 1B N-β-dimethylaminoethylbonyl 5-hydroxy-10-propoxybenzo[(Z
] Phenazine-6-carboxamide m. p. 65-6
6°C Example 19 N-β-dimethylaminoethyl 10-butoxy-5-
Hydroxy-9-methoxycarbonylbenzo[a cofenadine-6-carboxamide m. p. 171-17
2°C Example 2O N-β-dimethylaminoethyl 10-butoxy-9-
Butoxycarbonyl-[acofenazine-6-carboxamideff11.
102-104°C Example 21 N-β-dimethylaminoethyl 5,10-dihydroxy-9-methoxycarbonylbenzodine-6-carpoxamide m, p, 250°C (decomposition) Example 22 N-β-ethylaminoethyl 5 -Hydroxy-10-
Preparation of methoxy-9-methoxycarbonylbenzo[α]phenazine-6-carpoxamide A product was obtained in the same manner as in Example 1, using N-ethylethylenediamine in place of N,N-dimethylethylenediamine.
m、9.140〜142℃
実施例23
N−β−ジエチルアミンエチル 5−ヒドロキシ−10
−メトキシ−9−メトキシカルボニルベンゾ[α]フェ
ナジン−6−カルポキサミドの製造N.Nージメチルエ
チレンジアミンに代えてN.N−ジエチルエチレンジア
ミンを用い、実施例1と同様に処理して得た。m, 9.140-142°C Example 23 N-β-diethylamine ethyl 5-hydroxy-10
-Preparation of methoxy-9-methoxycarbonylbenzo[α]phenazine-6-carpoxamideN. N. in place of N-dimethylethylenediamine. It was obtained in the same manner as in Example 1 using N-diethylethylenediamine.
m.p. 164〜165℃
実施例24
N−7−シメチルアミノブロピルー5−ヒドロキシ−1
0−メトキシ−9−メトキシカルボニルベンゾ[α]フ
ェナジン−6−カルポキサミドの製造N.Nージメチル
エチレンジアミンに代えてN.N−ジメチル−1.3−
プロパンジアミンを用い、実施例1と同様に処理して得
た。m. p. 164-165°C Example 24 N-7-dimethylaminopropyl-5-hydroxy-1
Preparation of 0-methoxy-9-methoxycarbonylbenzo[α]phenazine-6-carpoxamideN. N. in place of N-dimethylethylenediamine. N-dimethyl-1,3-
It was obtained in the same manner as in Example 1 using propanediamine.
111、2. 143〜145℃
実施例z5
N−β−ジメチルアミノエチル
ボニル−5−ヒドロキシ−10−メトキシベンゾ[α]
フェナジン−6−カルポキサミドの製造実施例1で得た
N−β−ジメチルアミノエチル5−ヒドロキシ−10−
メトキシ−9−メトキシカルボニルベンゾ
21、52gを、濃硫酸8mlを加えたn−ブタノール
400mlに懸濁し、5時間還流した.n−ブタノール
を減圧下に留去し、残留物を重盲水に加え、得られた固
形物を濾取し、クロロホルム−エタノールより再結晶し
て表題の化合物を得た。111, 2. 143-145°C Example z5 N-β-dimethylaminoethylbonyl-5-hydroxy-10-methoxybenzo[α]
Production of phenazine-6-carpoxamide N-β-dimethylaminoethyl 5-hydroxy-10- obtained in Example 1
21.52 g of methoxy-9-methoxycarbonylbenzo was suspended in 400 ml of n-butanol to which 8 ml of concentrated sulfuric acid was added, and the mixture was refluxed for 5 hours. n-Butanol was distilled off under reduced pressure, the residue was added to double-blind water, and the resulting solid was collected by filtration and recrystallized from chloroform-ethanol to obtain the title compound.
m.p. 116〜117℃ 収量21.41gn−ブ
タノールに代えて他のアルコールを用い、実施例25と
同様に処理して以下の対応する化合物Iを得た。m. p. 116-117°C Yield: 21.41 gn The following corresponding compound I was obtained by treating in the same manner as in Example 25, using another alcohol in place of gn-butanol.
実施例26
N−β−ジメチルアミノエチル 9−エトキシカルボニ
ル−5−ヒドロキシ−10−メトキシベンゾ[α]フェ
ナジンー6ーカルポキサミド
m,p. 171〜174℃
実施例27
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−プロポキシカルボニルベンゾ[αコフ
エナジンー6ーカルポキサミドm.p. 164〜1
66℃
実施例2B
N−β−ジメチルアミンエチル 5−ヒドロキシ−10
−メトキシ−9−インプロポキシカルボニルベンゾ[α
]フェナジンー6ーカルポキサミドm.p. 162〜
163℃
実施例29
N−β−ジメチルアミノエチル 9−イソブトキシカル
ボニル−5−ヒドロキシ−10−メトキシベンゾ[(Z
lフェナジン−6−カルボキサミドm.p. 149〜
151℃
実施例3O
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−ペンチルオキシカルボニルベンゾ
”、p. 119〜120℃
実施例31
N−β−ジメチルアミノエテル 5−ヒドロキシ−10
−メトキシ−9−イソペンチルオキシカルボニルベンゾ
[αコフエナジンー6ーカルボキサミドm.9. 14
0〜143℃
実施例32
N−β−ジメチルアミノエチル 9−シクロペンチルオ
キシカルボニル 5−ヒドロキシ−10−メトキシ−ベ
ンゾ[α]フェナジンー6ーカルポキサミドm.p.
155〜158℃
実施例33
N−β−ジメチルアミノエチル 9−へキシル才キジカ
ルボニル−5−ヒドロキシ−10−メトキシベンゾ[α
コフエナジンー6−カルボキサミドm、p、 95〜9
6℃
実施例34
N−β−ジメチルアミノエチル 9−シクロへキシルオ
キシカルボニル−5−ヒドロキシ−10−メトキシベン
ゾ[α]フェナジンー6−カルポキサミドff1.I)
、 155〜158℃
実施例35
N−β−ジメチルアミノエチル 9−ヘプチルオキシカ
ルボニル−
ゾ[(2]フェナジン−6−カルポキサミド+11.p
. 88〜89℃
実施例36
N−β−ジメチルアミンエチル 5−ヒドロキシ−10
−メトキシ−9−オクチルオキシカルボニルベンゾ[(
2]フェナジン−6−カルボキサミドm.p. 98
〜103℃
実施例37
N−β−ジメチルアミノエチル 9−デシルオキシカル
ボニル−5−ヒドロキシ−10−メトキシベンゾ[αコ
フエナジンー6ーカルポキサミドm.p. 97〜1
00℃
実施例38
N−β−ジメチルアミンエチル 5−ヒドロキシ−10
−メトキシ−9−ペンタデシルオキシ力ルポニルベンゾ
[α]フェナジンー6ーカルポキサミドm.p. 96
〜98.5℃
実施例39
N−β−ジメチルアミノエチル 9−ベンジルオキシカ
ルボニル−5−ヒドロキシ−10−メトキシベンゾ[(
2]フェナジン−6−カルボキサミドm.p. 125
〜127℃
実施例4O
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−メチルカルバモイルベンゾ[α]フェ
ナジン−6−カルポキサミドの製造実施例1で得たN−
β−ジメチルアミノエチル5−ヒドロキシ−10−メト
キシ−9−メトキシカルボニルベンゾ[a]フェナジン
−6−カルボキサミド2、 24gをジオキサン900
mllに溶解し、40%メチルアミン水溶液100ml
を加えて6日間室温下に放置した。反応液を減圧下に乾
固し、残渣をクロロホルム−エタノールより再結晶して
表題の化合物を得た。Example 26 N-β-dimethylaminoethyl 9-ethoxycarbonyl-5-hydroxy-10-methoxybenzo[α]phenazine-6-carpoxamide m,p. 171-174°C Example 27 N-β-dimethylaminoethyl 5-hydroxy-10
-Methoxy-9-propoxycarbonylbenzo[αcohuenazine-6-carpoxamide m. p. 164-1
66°C Example 2B N-β-dimethylamine ethyl 5-hydroxy-10
-methoxy-9-inpropoxycarbonylbenzo[α
] Phenazine-6-carpoxamide m. p. 162~
163°C Example 29 N-β-dimethylaminoethyl 9-isobutoxycarbonyl-5-hydroxy-10-methoxybenzo[(Z
l phenazine-6-carboxamide m. p. 149~
151°C Example 3O N-β-dimethylaminoethyl 5-hydroxy-10
-Methoxy-9-pentyloxycarbonylbenzo”, p. 119-120°C Example 31 N-β-dimethylaminoether 5-hydroxy-10
-Methoxy-9-isopentyloxycarbonylbenzo[αcohuenazine-6-carboxamide m. 9. 14
0-143°C Example 32 N-β-dimethylaminoethyl 9-cyclopentyloxycarbonyl 5-hydroxy-10-methoxy-benzo[α]phenazine-6-carpoxamide m. p.
155-158°C Example 33 N-β-dimethylaminoethyl 9-hexyl carbonyl-5-hydroxy-10-methoxybenzo[α
Cofenadine-6-carboxamide m, p, 95-9
6°C Example 34 N-β-dimethylaminoethyl 9-cyclohexyloxycarbonyl-5-hydroxy-10-methoxybenzo[α]phenazine-6-carpoxamide ff1. I)
, 155-158°C Example 35 N-β-dimethylaminoethyl 9-heptyloxycarbonyl-zo[(2]phenazine-6-carpoxamide + 11.p
.. 88-89°C Example 36 N-β-dimethylamine ethyl 5-hydroxy-10
-methoxy-9-octyloxycarbonylbenzo[(
2] Phenazine-6-carboxamide m. p. 98
~103°C Example 37 N-β-dimethylaminoethyl 9-decyloxycarbonyl-5-hydroxy-10-methoxybenzo[α cofenadine-6-carpoxamide m. p. 97-1
00°C Example 38 N-β-dimethylamine ethyl 5-hydroxy-10
-Methoxy-9-pentadecyloxyluponylbenzo[α]phenazine-6-carpoxamide m. p. 96
~98.5°C Example 39 N-β-dimethylaminoethyl 9-benzyloxycarbonyl-5-hydroxy-10-methoxybenzo[(
2] Phenazine-6-carboxamide m. p. 125
~127°C Example 4O N-β-dimethylaminoethyl 5-hydroxy-10
-Methoxy-9-methylcarbamoylbenzo[α]phenazine-6-carpoxamide N- obtained in Example 1
β-Dimethylaminoethyl 5-hydroxy-10-methoxy-9-methoxycarbonylbenzo[a]phenazine-6-carboxamide 2. 24 g was added to 900 g of dioxane.
100ml of 40% methylamine aqueous solution
was added and left at room temperature for 6 days. The reaction solution was dried under reduced pressure, and the residue was recrystallized from chloroform-ethanol to obtain the title compound.
m.p. 245〜248℃ 収量2.OOgメチルア
ミ゛ンに代えて他のアミンを用い、実施例40と同様に
処理して以下の対応する化合物を得た。m. p. 245-248℃ Yield 2. The following corresponding compound was obtained by processing in the same manner as in Example 40, using another amine in place of OOg methylamine.
実施例41
N−β−ジメチルアミノエチル 5−ヒドロキシ−10
−メトキシ−9−プロピルカルバモイルベンゾ[αコフ
エナジンー6ーカルボキサミドm.p. 224〜2
26.5℃
実施例42
N−β−ジメチルアミンエチル 9−ブチルカルバモイ
ル−5−ヒドロキシ−10−メトキシベンゾ[α]フェ
ナジンー6ーカルポキサミド
m.p、221〜224℃
実施例43
N−β−ジメチルアミノエチル 5−ヒドロキシ−9−
メトキシカルボニルベンゾ[α]フェナジン−6−カル
ポキサミドの製造
実施例2で得たN−β−ジメチルアミノエチル9−カル
ボキシ−5−ヒドロキシベンゾ[(2]フェナジン−6
−カルポキサミド1.45gをメタノール100mlに
懸濁し、過剰のジアゾメタン−エーテル溶液を加えた。Example 41 N-β-dimethylaminoethyl 5-hydroxy-10
-methoxy-9-propylcarbamoylbenzo[alpha]cohuenazine-6-carboxamide m. p. 224-2
26.5°C Example 42 N-β-dimethylamine ethyl 9-butylcarbamoyl-5-hydroxy-10-methoxybenzo[α]phenazine-6-carpoxamide m. p, 221-224°C Example 43 N-β-dimethylaminoethyl 5-hydroxy-9-
Production of methoxycarbonylbenzo[α]phenazine-6-carpoxamide N-β-dimethylaminoethyl 9-carboxy-5-hydroxybenzo[(2]phenazine-6 obtained in Example 2)
- 1.45 g of carpoxamide was suspended in 100 ml of methanol and excess diazomethane-ether solution was added.
反応液を減圧下に乾固し、残渣をシリカゲルカラムクロ
マトグラフィーにイ寸し、クロロホルム−メタノール(
10:1)で溶出した画分を集め、メタノールより再結
晶して表題の化合物を得た。The reaction solution was dried under reduced pressure, the residue was subjected to silica gel column chromatography, and chloroform-methanol (
The fractions eluted with 10:1) were collected and recrystallized from methanol to obtain the title compound.
m.p. 200〜203℃ 収量0. 71g実施例
44
N−β−ジメチルアミノエチル
5−ヒドロキシ−10−メトキシベンゾ[αコフェナジ
ン−6−カルポキサミドの製造
実施例1で得たN−β−ジメチルアミノエチル5−ヒド
ロキシ−10−メトキシ−9−メトキシカルボニルベン
ゾ[(Z]フェナジン−6−カルポキサミド4.48g
をメタノール80m1に懸濁し、水酸化カリ゛ウム1.
18gと水80tdの溶液を加えて5時間還流した。水
350m1およびドライアイスを加えて析出した結晶を
濾取し、乾燥後、N、N−ジメチルホルムアミド−エタ
ノールより再結晶して表題の化合物を得た。m. p. 200-203℃ Yield 0. 71g Example 44 N-β-dimethylaminoethyl 5-hydroxy-10-methoxybenzo[α Preparation of α-cofenazine-6-carpoxamide N-β-dimethylaminoethyl 5-hydroxy-10-methoxy-9 obtained in Example 1 -Methoxycarbonylbenzo[(Z]phenazine-6-carpoxamide 4.48g
was suspended in 80 ml of methanol, and 1.0 ml of potassium hydroxide was added.
A solution of 18 g and 80 td of water was added and refluxed for 5 hours. 350 ml of water and dry ice were added, and the precipitated crystals were collected by filtration, dried, and recrystallized from N,N-dimethylformamide-ethanol to obtain the title compound.
m、p、 232〜237℃
収量3.90g
試験例
[リンパ細胞性白血病P38Bによる試験コ(1〉実験
動物
DBA/2雌性マウスで継代したP388白血病細胞を
各1×10′個腹腔内に移植したCDF、雌性マウス(
5〜6週令1体重:17〜20g)を使用した。移植日
を第0日とした。m, p, 232-237°C Yield: 3.90 g Test example [Test using lymphocytic leukemia P38B (1) Experimental animal P388 leukemia cells passaged in DBA/2 female mice were injected intraperitoneally in 1 x 10 cells each. Transplanted CDF, female mice (
(5-6 week old, 1 body weight: 17-20 g) was used. The day of transplantation was defined as day 0.
(2)投与方法
化合物Iを0,5%アラビアゴム/生理食塩水に懸濁し
、1日1回、第1日から第5日まで計5回腹腔内投与し
た。比較薬物には5−フルオロウラシルを用い、生理食
塩水に溶解し、同様に投与した。対照群には0.5%ア
ラビアゴム/生理食塩水のみを同様に投与した。(2) Administration method Compound I was suspended in 0.5% gum arabic/physiological saline and intraperitoneally administered once a day, a total of 5 times from day 1 to day 5. 5-fluorouracil was used as a comparative drug, dissolved in physiological saline, and administered in the same manner. In the same manner, only 0.5% gum arabic/physiological saline was administered to the control group.
化合物Iまたは比較薬物を投与した処置群は1群8匹、
対照群は16匹であった。The treatment group administered Compound I or the comparative drug consisted of 8 animals per group;
The control group consisted of 16 animals.
(3)評価方法
効果判定は米国国立癌研究所(MCI)の効果判定基準
により行った。(3) Evaluation method Efficacy was evaluated based on the efficacy criteria of the US National Cancer Institute (MCI).
各群の生存動物を30日間記録し、処置群の生存日数中
央値(T)および対照群の生存日数中央値(C)から
T/CX100(%)
を計算した。Surviving animals in each group were recorded for 30 days, and T/CX100 (%) was calculated from the median survival days (T) of the treatment group and the median survival days (C) of the control group.
T/CX100値が125以上のとき有効ときれている
。It is considered valid when the T/CX100 value is 125 or more.
(4)試験結果 試験結果は、表−2に示した。(4) Test results The test results are shown in Table-2.
本発明の化合物Iは大きいT/CX100値と幅広い用
量での有効性を示した。Compound I of the invention showed large T/CX100 values and efficacy over a wide range of doses.
表−27ウスP388に対する効果 (註)Table-27 Effect on mouse P388 (Note)
Claims (1)
水酸基またはアルコキシ基を示し、 R^2は式、 −COOR^5 (式中、R^5は水素原子、直鎖もしくは分枝鎖のアル
キル基、シクロアルキル基、ベンジル基またはフェニル
基を示す。)または式、 ▲数式、化学式、表等があります▼ (式中、R^6およびR^7は、同一もしくは異なって
水素原子、低級アルキル基または互いに結合して隣接す
る窒素原子と共に複素環を形成する基を示す。)で表わ
される基を示し、R^3およびR^4は同一もしくは異
なって水素原子または低級アルキル基を示し、nは2ま
たは3を示す。]で表わされるベンゾ[a]フェナジン
誘導体。[Claims] General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, R^1 is a hydrogen atom, a halogen atom, a methyl group,
It represents a hydroxyl group or an alkoxy group, and R^2 represents the formula, -COOR^5 (wherein R^5 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, a benzyl group, or a phenyl group. ) or formulas, ▲numeric formulas, chemical formulas, tables, etc.▼ (In the formulas, R^6 and R^7 are the same or different and are hydrogen atoms, lower alkyl groups, or bonded to each other to form a heterocyclic ring together with adjacent nitrogen atoms. ), R^3 and R^4 are the same or different and represent a hydrogen atom or a lower alkyl group, and n represents 2 or 3. ] A benzo[a]phenazine derivative represented by.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6509985 | 1985-03-29 | ||
JP60-65099 | 1985-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6272A true JPS6272A (en) | 1987-01-06 |
JPH0513149B2 JPH0513149B2 (en) | 1993-02-19 |
Family
ID=13277123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61064410A Granted JPS6272A (en) | 1985-03-29 | 1986-03-20 | Benzo(a)phenazine derivative |
Country Status (9)
Country | Link |
---|---|
US (1) | US4686292A (en) |
EP (1) | EP0196910B1 (en) |
JP (1) | JPS6272A (en) |
KR (1) | KR930002279B1 (en) |
AT (1) | ATE59642T1 (en) |
CA (1) | CA1248106A (en) |
DE (1) | DE3676333D1 (en) |
ES (1) | ES8706650A1 (en) |
ZA (1) | ZA862183B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100441247B1 (en) * | 2001-07-31 | 2004-07-21 | 학교법인 이화학당 | Pyridophenazinedione derivatives and the method thereof and anticancer agents containing them |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6231894B1 (en) | 1999-10-21 | 2001-05-15 | Duke University | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5959674A (en) * | 1982-09-29 | 1984-04-05 | Taisho Pharmaceut Co Ltd | Benzo(a)phenazine derivative |
-
1986
- 1986-03-10 US US06/838,153 patent/US4686292A/en not_active Expired - Fee Related
- 1986-03-18 CA CA000504378A patent/CA1248106A/en not_active Expired
- 1986-03-20 JP JP61064410A patent/JPS6272A/en active Granted
- 1986-03-24 ZA ZA862183A patent/ZA862183B/en unknown
- 1986-03-26 ES ES553500A patent/ES8706650A1/en not_active Expired
- 1986-03-28 KR KR1019860002313A patent/KR930002279B1/en not_active IP Right Cessation
- 1986-04-01 DE DE8686302395T patent/DE3676333D1/en not_active Expired - Fee Related
- 1986-04-01 AT AT86302395T patent/ATE59642T1/en not_active IP Right Cessation
- 1986-04-01 EP EP86302395A patent/EP0196910B1/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100441247B1 (en) * | 2001-07-31 | 2004-07-21 | 학교법인 이화학당 | Pyridophenazinedione derivatives and the method thereof and anticancer agents containing them |
Also Published As
Publication number | Publication date |
---|---|
KR860007222A (en) | 1986-10-08 |
CA1248106A (en) | 1989-01-03 |
EP0196910A3 (en) | 1987-09-02 |
US4686292A (en) | 1987-08-11 |
KR930002279B1 (en) | 1993-03-27 |
ES553500A0 (en) | 1987-06-16 |
ATE59642T1 (en) | 1991-01-15 |
JPH0513149B2 (en) | 1993-02-19 |
EP0196910A2 (en) | 1986-10-08 |
ZA862183B (en) | 1986-11-26 |
EP0196910B1 (en) | 1991-01-02 |
ES8706650A1 (en) | 1987-06-16 |
DE3676333D1 (en) | 1991-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1039734A (en) | 5-sulphamyl-benzoic acid derivatives | |
AU634125B2 (en) | (diethylamino-n-oxide) ethylamino-dihydroxyanthracene-9, 10-dione derivatives | |
DE2844292A1 (en) | PYRROLOBENZODIAZEPINE, THE METHOD OF MANUFACTURING THEREOF AND THEIR USE FOR THE TREATMENT OF TUMOR DISEASES | |
US3349088A (en) | Therapeutically valuable 1, 2-dihyro-1, 2, 4-benzotriazine derivatives and process for preparation thereof | |
DE2905877A1 (en) | NEW AMINOPROPANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
US20090149488A1 (en) | Tetrahydroprotoberberine Compounds, the Synthetic Method and the Use Thereof | |
FR2638161A1 (en) | New 2-benzoylimidazo[1,2-a]pyridine derivatives and their salts, process for their preparation, their application as medicaments and the pharmaceutical compositions containing them | |
IE47997B1 (en) | The use of 4,9-dihydro-4,9-dioxo-1h-naphtho(2,3-d)triazoles,their preparation and antiallergic compositions | |
JPS6272A (en) | Benzo(a)phenazine derivative | |
HU197746B (en) | Process for producing xantin derivatives and pharmaceutical compositions containing them | |
US4039672A (en) | N-(1'-allypyrrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide and its pharmaceutically acceptable salts | |
US4616013A (en) | Fused thiadiazines | |
US3862958A (en) | Manufacture of indazoles | |
US4161531A (en) | Diuretic and saluretic 5-sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent | |
US4508735A (en) | Anti-arrhythmic N-alkanoylaminoalkyl fluorenes | |
FI57103C (en) | EXAMINATION OF ANTI-METAL ACTIVATION 5- (1-ALLYL-2-PYRROLIDINYLMETHYLCARBAMOYL) -6-METHOXY-1H-BENZOTRIAZOLE | |
JP2821812B2 (en) | Method for producing aminophenol salts | |
AT356095B (en) | METHOD FOR PRODUCING NEW, HETEROCYCLICALLY SUBSTITUTED 5-SULFAMOYL-BENZOESAE DERIVATIVES AND THEIR SALTS | |
DE2718494C2 (en) | ||
US2756232A (en) | Substituted 1-carbonyl-4-carbamyl piperazines and method of preparing the same | |
US3078286A (en) | alpha-naphthol derivatives | |
DE2760370C2 (en) | ||
BE738727A (en) | Anti inflammatory analgesic and antipyretic indolyalkanoic - acids and derivs | |
KR790000999B1 (en) | Preparing method of n-(1'-allyl pyrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide | |
KR830000584B1 (en) | Method for preparing 5-sulfamoylbenzoic acid derivative having a heterocyclic substituent |